Benzinga - Mon, 26 Apr 2021 05:25:18 -0400
Benzinga - Tue, 09 Mar 2021 17:10:06 -0400
Benzinga - Tue, 09 Mar 2021 05:09:40 -0400
Benzinga - Wed, 17 Feb 2021 09:27:43 -0400
Benzinga - Thu, 11 Feb 2021 15:08:57 -0400
Benzinga - Thu, 11 Feb 2021 13:44:29 -0400
Benzinga - Thu, 11 Feb 2021 07:41:10 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Lyra Therapeutics Inc a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-11
REV
Q4 2020Est.ActualSurprise
EPS-0.560-0.460 0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
LYRALyra Therapeutics0.12%109M

Lyra Therapeutics Company Questions & Answers

Q

How do I buy Lyra Therapeutics (LYRA) stock?

A

You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lyra Therapeutics's (LYRA) main competitors?

A

Other companies in Lyra Therapeutics’s space includes: Opiant Pharmaceuticals (NASDAQ:OPNT), Baudax Bio (NASDAQ:BXRX) and Cocrystal Pharma (NASDAQ:COCP).

Q

What is the target price for Lyra Therapeutics?

A

The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by B of A Securities on 2020-05-26. The analyst firm set a price target for 21.00 expecting LYRA to rise to within 12 months (a possible 149.70% upside). 2 analyst firms have reported ratings in the last year.

Q

How much is Lyra Therapeutics (LYRA) stock ?

A

The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $8.41 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Lyra Therapeutics (LYRA) dividend?

A

There are no upcoming dividends for Lyra Therapeutics.

Q

When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?

A
Lyra Therapeutics’s Q2 earnings are confirmed after-market from now on August 4, 2021.
Q

When is the upcoming split for LYRA?

A

There is no upcoming split for Lyra Therapeutics.